Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
Tissue biopsy is essential for NSCLC diagnosis and treatment management. Over the past decades, liquid biopsy has proven to be a powerful tool in clinical oncology, isolating tumor-derived entities from the blood. Liquid biopsy permits several advantages over tissue biopsy: it is non-invasive, and i...
Main Authors: | Elisa Bertoli, Elisa De Carlo, Debora Basile, Diego Zara, Brigida Stanzione, Monica Schiappacassi, Alessandro Del Conte, Michele Spina, Alessandra Bearz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/10803 |
Similar Items
-
Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC
by: Elisa De Carlo, et al.
Published: (2024-02-01) -
Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications
by: Alessandro Del Conte, et al.
Published: (2022-06-01) -
The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation
by: Alessandra Bearz, et al.
Published: (2022-06-01) -
Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
by: Elisa De Carlo, et al.
Published: (2022-06-01) -
Acquired Resistance to Osimertinib in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?
by: Elisa Bertoli, et al.
Published: (2022-06-01)